Inhibrx Biosciences, Inc. (INBX)
Across 8 earnings reports since Aug 13, 2024, Inhibrx Biosciences, Inc. (INBX) has a clear post-earnings pattern. It moves ±3.92% on average after reporting and finishes higher 37.5% of the time. Its largest post-earnings gain was +10.89% (May 14, 2025) and its largest decline was -6.53% (May 14, 2026). The next earnings report is predicted for 2026-08-13 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
8
Avg Abs. Movement
±3.92%
Positive %
37.5%
Negative %
62.5%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | ☽ POST | $117.50 | $118.79 | $115.98 | 16,795 | -6.53% | open_in_new |
| Mar 19, 2026 | ☽ POST | $68.18 | $68.18 | $64.87 | 184,000 | -6.09% | open_in_new |
| Nov 14, 2025 | ☽ POST | $72.90 | $84.07 | $79.13 | 600,100 | -2.25% | open_in_new |
| Aug 13, 2025 | ☽ POST | $22.04 | $23.59 | $23.57 | 83,700 | +1.57% | open_in_new |
| May 14, 2025 | ☽ POST | $11.25 | $11.31 | $10.84 | 77,200 | +10.89% | open_in_new |
| Mar 17, 2025 | ☽ POST | $14.18 | $14.54 | $13.94 | 41,400 | +0.43% | open_in_new |
| Nov 14, 2024 | ☽ POST | $15.38 | $15.47 | $14.33 | 112,400 | -3.49% | open_in_new |
| Aug 13, 2024 | ☽ POST | $11.24 | $11.62 | $11.30 | 56,200 | -0.09% | open_in_new |
Earnings Count
8
Total earnings in dataset
Avg Abs. Movement
±3.92%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260604 | open_in_new SEC.gov |
| 4 | 20260604 | open_in_new SEC.gov |
| 4 | 20260604 | open_in_new SEC.gov |
| 4 | 20260604 | open_in_new SEC.gov |
| 8-K | 20260603 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260514 | open_in_new SEC.gov |
| 8-K | 20260514 | open_in_new SEC.gov |
| 4 | 20260427 | open_in_new SEC.gov |
Frequently asked about INBX earnings
When does Inhibrx Biosciences, Inc. report earnings next? expand_more
Inhibrx Biosciences, Inc. (INBX)'s next earnings date is estimated for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does INBX stock move after earnings? expand_more
Over 8 reports, INBX has moved an average of ±3.92% the session after earnings, closing higher 37.5% of the time.
What was INBX's biggest post-earnings move? expand_more
INBX's largest post-earnings gain on record was +10.89% on May 14, 2025, and its largest decline was -6.53% on May 14, 2026.
Where can I find Inhibrx Biosciences, Inc.'s SEC filings? expand_more
All of Inhibrx Biosciences, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right